Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chronic wounds are of high incidence, difficult to heal, and can cause serious consequences if not properly treated. Doxycycline (
DCH
) is a broad-spectrum antibiotic and matrix metalloproteinases inhibitor, which has prominent efficacy for chronic wound treatment. Topical
DCH
treatment is the common administration route for chronic wounds in clinic but may result in low therapeutic efficacy and cause skin irritation at high
DCH
concentration, since it is difficult to control local drug concentration in the wounds and maintain the effective
DCH
concentration for a long time. In this study, we prepared
DCH
-encapsulated polylactide (
DCH
/
PLA
) nanofibers by a simple electrospinning method. Imaging studies showed that smooth and continuous
DCH
/
PLA
nanofibers with homogeneous
DCH
distribution were obtained at varied
DCH
loading content in the range of 5-30%. Mechanical property, water vapour permeability and absorbency of these nanofibers could meet the requirement as wound dressings. By adjusting
DCH
loading content, the wettability of the nanofibers could be transferred from hydrophobic to hydrophilic, and the release rate of
DCH
could be controlled in a sustained manner from three days to two weeks. Results of cytotoxicity and antibacterial test indicated that
DCH
/
PLA
nanofibers showed good cytocompatibility to L929 mouse fibroblast cells and exhibited positive antibacterial activity against Escherichia coli, suggesting its ability to treat/prevent infectious wounds. For full-thickness wound treatment of diabetic rats,
DCH
/
PLA
nanofiber mats can speed up wound healing to a higher extent than topical
DCH
treatment, due to the sustained release of
DCH
with less side effects. Our results indicate that
DCH
/
PLA
nanofiber mats hold great potential as wound dressings for chronic wound treatment.
...
PMID:Polylactide nanofibers delivering doxycycline for chronic wound treatment. 3149 63